{{for|the medication used to treat nausea|Hyoscine hydrobromide}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 447379730
| IUPAC_name = [7(''S'')-(1α,2β,4β,5α,7β)]-9-butyl-7-(3-hydroxy-<br />1-oxo-2-phenylpropoxy)-9-methyl-3-oxa-<br />9-azonitricyclo[3.3.1.0(2,4)]nonane
| image = Butylscopolamine skeletal.svg

<!-- Clinical data -->
| tradename = Buscopan, others
| pregnancy_AU = B2
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = S2
| legal_CA = OTC (Pharmacist only)
| legal_UK = GSL
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration = By mouth, rectal, [[intravenous therapy|intravenous]]

<!-- Pharmacokinetic data -->
| bioavailability = <1%
| protein_bound = Low
| metabolism =  
| elimination_half-life = 5 hours
| excretion = [[Kidney|Renal]] (50%) {{citation needed|date=May 2014}} and fecal

<!-- Identifiers -->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 149-64-4
| ATC_prefix = A03
| ATC_suffix = BB01
| PubChem = 160883
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1256901
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  DB09300
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 16736107
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 2Z3E1OF81V

<!-- Chemical data -->
| C=21 | H=30 | N=1 | O=4 | charge = + 
| molecular_weight = 360.467 g/mol
| smiles = [Br-].OC[C@H](c1ccccc1)C(=O)O[C@@H]2C[C@@H]3[C@H]4O[C@H]4[C@H](C2)[N+]3(C)CCCC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C21H30NO4.BrH/c1-3-4-10-22(2)17-11-15(12-18(22)20-19(17)26-20)25-21(24)16(13-23)14-8-6-5-7-9-14;/h5-9,15-20,23H,3-4,10-13H2,1-2H3;1H/q+1;/p-1/t15-,16-,17-,18+,19-,20+,22?;/m1./s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = HOZOZZFCZRXYEK-GSWUYBTGSA-M
}}

<!-- Definition and medical uses -->
'''Hyoscine butylbromide''', also known as '''scopolamine butylbromide'''<ref name=Huo2001>{{cite book|last1=Juo|first1=Pei-Show|title=Concise Dictionary of Biomedicine and Molecular Biology.|date=2001|publisher=CRC Press|location=Hoboken|isbn=9781420041309|page=570|edition=2nd|url=https://books.google.ca/books?id=Y4DLBQAAQBAJ&pg=PA570|deadurl=no|archiveurl=https://web.archive.org/web/20151208061939/https://books.google.ca/books?id=Y4DLBQAAQBAJ&pg=PA570|archivedate=2015-12-08|df=}}</ref> and sold under the brandname '''Buscopan''',<ref name = TGA2010Label/> is a medication used to treat crampy [[abdominal pain]], [[esophageal spasm]]s, [[renal colic]], and [[bladder spasms]].<ref name=TGA2010Label>{{cite journal|title=Buscopan Tablets and Ampoules|date=8 November 2010|accessdate=22 October 2013|work=|publisher=Therapeutic Goods Administration, Australia|url=https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-07866-3|deadurl=no|archiveurl=https://web.archive.org/web/20170330184643/https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-07866-3|archivedate=30 March 2017|df=}}</ref><ref name=Ric2015>{{cite book|last1=Hamilton|first1=Richart|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=270}}</ref> It is also used to improve [[death rattle|respiratory secretions]] at the [[End-of-life care|end of life]].<ref>{{cite book|last1=Paice|first1=Judith|title=Care of the Imminently Dying|date=2015|publisher=Oxford University Press|isbn=9780190244309|page=43|url=https://books.google.ca/books?id=QCTYCgAAQBAJ&pg=PT43|deadurl=no|archiveurl=https://web.archive.org/web/20151208053014/https://books.google.ca/books?id=QCTYCgAAQBAJ&pg=PT43|archivedate=2015-12-08|df=}}</ref> Hyoscine butylbromide can be taken by mouth, [[intramuscular|injection into a muscle]], or [[intravenous|into a vein]].<ref name = TGA2010Label/>

<!-- Side effects and mechanism -->
Side effects may include sleepiness, vision changes, triggering of [[glaucoma]], and [[anaphylaxis|severe allergies]].<ref name = TGA2010Label/> Sleepiness however, is uncommon.<ref>{{cite book|title=Handbook of Palliative Care|date=2012|publisher=Wiley|location=New York|isbn=9781118426814|page=570|edition=3rd|url=https://books.google.ca/books?id=aXP4_H9OX_AC&pg=PT570|deadurl=no|archiveurl=https://web.archive.org/web/20151208054721/https://books.google.ca/books?id=aXP4_H9OX_AC&pg=PT570|archivedate=2015-12-08|df=}}</ref> It is unclear if it is safe in [[pregnancy]].<ref name = TGA2010Label/> It is an [[anticholinergic agent]],<ref name = TGA2010Label/> which does not have much effect on the [[central nervous system|brain]].<ref name="Oxford University Press">{{cite book|last1=Hanks|first1=Geoffrey|title=Oxford textbook of palliative medicine|date=2011|publisher=Oxford University Press|location=Oxford [etc.]|isbn=9780199693146|page=805|edition=4th|url=https://books.google.ca/books?id=Fk9uBAAAQBAJ&pg=PA805|deadurl=no|archiveurl=https://web.archive.org/web/20151208051001/https://books.google.ca/books?id=Fk9uBAAAQBAJ&pg=PA805|archivedate=2015-12-08|df=}}</ref>

<!-- History, society, and culture -->
It is on the [[World Health Organization's List of Essential Medicines]], the most effective and safe medicines needed in a [[health system]].<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=8 December 2016|date=April 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|archivedate=13 December 2016|df=}}</ref> It is not available in the United States.<ref>{{cite book|last1=Territo|first1=editor, Dennis A. Casciato ; associate editor, Mary C.|title=Manual of clinical oncology|date=2012|publisher=Wolters Kluwer/Lippincott Williams & Wilkins Health|location=Philadelphia|isbn=9781451115604|page=146|edition=7th|url=https://books.google.ca/books?id=4ggoPDgZx2YC&pg=PA146|deadurl=no|archiveurl=https://web.archive.org/web/20151208043312/https://books.google.ca/books?id=4ggoPDgZx2YC&pg=PA146|archivedate=2015-12-08|df=}}</ref> The wholesale cost in the [[developing world]] is 0.004 to 0.11 USD per pill as of 2014.<ref>{{cite web|title=Hyoscine Butylbromide|url=http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=BUT10T&s_year=2014&year=2014&str=10%20mg&desc=Hyoscine%20Butylbromide&pack=new&frm=TAB-CAP&rte=PO&class_code2=9UA&supplement=&class_name=%289UA%29Items%20unclassified%20on%20WHO%20Essential%20Medicines%20List%3Cbr%3E|website=International Drug Price Indicator Guide|accessdate=4 December 2015|deadurl=no|archiveurl=https://web.archive.org/web/20170510161046/http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=BUT10T&s_year=2014&year=2014&str=10%20mg&desc=Hyoscine%20Butylbromide&pack=new&frm=TAB-CAP&rte=PO&class_code2=9UA&supplement=&class_name=%289UA%29Items%20unclassified%20on%20WHO%20Essential%20Medicines%20List%3Cbr%3E|archivedate=10 May 2017|df=}}</ref> It is manufactured from [[hyoscine hydrobromide|hyoscine]] which occurs naturally in the plant [[Atropa belladonna|deadly nightshade]].<ref>{{cite book|last1=Twycross|first1=Robert|title=Introducing palliative care|date=2003|publisher=Radcliffe Medical Press|location=Oxford|isbn=9781857759150|page=172|edition=4th|url=https://books.google.ca/books?id=YmMwVnGTNiYC&pg=PA172|deadurl=no|archiveurl=https://web.archive.org/web/20151208071827/https://books.google.ca/books?id=YmMwVnGTNiYC&pg=PA172|archivedate=2015-12-08|df=}}</ref>

==Medical uses==
[[File:Butylscopolamine.jpg|thumb|A package of injectable buscopan]]
Hyoscine butylbromide is effective in treating crampy [[abdominal pain]].<ref>{{ cite journal | author = Tytgat, G. N. | title = Hyoscine Butylbromide: A Review of its Use in the Treatment of Abdominal Cramping and Pain | journal = Drugs | year = 2007 | volume = 67 | issue = 9 | pages = 1343–1357 | pmid = 17547475 | doi=10.2165/00003495-200767090-00007}}</ref>

Hyoscine butylbromide is effective in reducing the duration of the first stage of labour, and it is not associated with any obvious adverse outcomes in mother or neonate.<ref>{{cite journal |author1=Samuels, L. A. |author2=Christie, L. |author3=Roberts-Gittens, B. |author4=Fletcher, H. |author5=Frederick, J. | title = The effect of hyoscine butylbromide on the first stage of labour in term pregnancies | journal = BJOG | year = 2007 | volume = 114 | issue = 12 | pages = 1542–1546 | pmid = 17903230 | doi = 10.1111/j.1471-0528.2007.01497.x }}</ref>

It is also used during [[abdominal]] or pelvic [[MRI]] or [[CT scan]]s to improve the quality of pictures.<ref>{{cite web | title=Hyoscine butylbromide (Buscopan®) | url=http://www.guysandstthomas.nhs.uk/resources/patient-information/radiology/hyoscine-butylbromide-buscopan.pdf | publisher=[[Guy's and St Thomas' NHS Foundation Trust]] | location=UK | date=July 2014 | accessdate=16 June 2016 | deadurl=no | archiveurl=https://web.archive.org/web/20160808085805/http://www.guysandstthomas.nhs.uk/resources/patient-information/radiology/hyoscine-butylbromide-buscopan.pdf | archivedate=8 August 2016 | df= }}</ref>

==Side effects==
As little of the medication crosses the blood brain barrier it has less effects on the [[central nervous system|brain]] and therefore has reduced occurrence of the centrally-mediated effects (such as [[delusions]], [[somnolence]], and inhibition of motor-functions) which hinder the usefulness of some other anticholinergic drugs.<ref name="Oxford University Press"/> Hyoscine butylbromide is still capable of impacting the [[chemoreceptor trigger zone]] due to the lack of a well-developed blood-brain-barrier in the [[medulla oblongata]], which potentiates the [[antiemetic]] effects that it produces via local action on the [[smooth muscle]] of the [[gastrointestinal tract]].<ref>{{cite journal|title=Treating nausea and vomiting in palliative care: a review|journal=Clinical Intervention of Aging|author=Paul Glare, Jeanna Miller, Tanya Nikolova, and Roma Tickoo|PMC=3180521|date=12 September 2011}}</ref>

==Pharmacology==
It is a [[quaternary ammonium compound]] and a semisynthetic derivative of [[hyoscine hydrobromide]] (scopolamine). The attachment of the butyl-bromide moiety effectively prevents the movement of this drug across the [[blood–brain barrier]], effectively minimising undesirable [[central nervous system]] side effects associated with scopolamine/hyoscine.

==Abuse==
Hyoscine butylbromide is not centrally active and has a low incidence of abuse.{{citation needed|date=June 2016}}
{{-}}
==References==
{{reflist}}

{{Drugs for functional gastrointestinal disorders}}
{{Muscarinic acetylcholine receptor modulators}}

[[Category:Muscarinic antagonists]]
[[Category:Chemical substances for emergency medicine]]
[[Category:Peripherally selective drugs]]
[[Category:Propionates]]
[[Category:Quaternary ammonium compounds]]
[[Category:World Health Organization essential medicines]]
[[Category:RTT]]